about
Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillinPotential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsEffect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.Dose-dependent pharmacokinetics of mezlocillin in rats.Pharmacokinetics of two multiple-dose mezlocillin regimensEffect of saturable clearance during high-dose mezlocillin therapy.Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testingMezlocillin enteral absorption in rabbits.Mezlocillin disposition in chronic hemodialysis patients.Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairmentMezlocillin pharmacokinetics in pediatric oncology patientsMezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteersMezlocillin pharmacokinetics in patients with normal and impaired renal functionsComparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.Microbiology, pharmacology, and clinical use of mezlocillin sodium.Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base.
P2860
Q33731171-AD066315-9C44-4929-8DCA-F95D9122E5C2Q33731809-222BB558-428D-49B5-ABA0-F984AF60F31CQ33740774-C393CE8A-C652-4E59-A686-C76C7A3FA676Q33742036-E8786DB5-63C7-4095-8174-275C5FCA8B4EQ35306618-75C2AE12-7133-4739-AB80-2BD50A49E80DQ35640493-EC948E15-4CDD-44B6-95B7-A07682FC6A43Q35671169-DEE873C7-CF58-4309-8AF9-E08B6F67DA56Q35671591-F72A2503-7F2C-47EA-895F-802B87048383Q35671969-832BC4B0-A5D8-4BE5-A939-AEED114FD51BQ35674361-2115C428-333A-4BC9-A29C-0577B29ABE4CQ35756222-2D4BE201-C39F-4CCD-9B90-2C59349BE2E1Q35760512-F472B85A-4110-4AA0-B220-4DEE6AB7530AQ35767452-0AE419E4-9650-4FB6-A869-C3D6266BCEAAQ36485726-9E30EA69-FBA8-4F2B-95EA-5FBD724DA202Q39834921-52AAB047-2F1F-411B-A52A-34EDB07AE205Q40114434-C2F0D1AE-0E7D-4A33-A106-F17D2A2461E1Q40281587-F815ABFA-F1FE-4016-B6C1-5A84F2D546E8Q40281838-65C2F2B7-72C9-497F-9B33-04DCB75B4584Q42285255-486C4F8F-AB4E-4DA4-B385-28583D021F66
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Pharmacokinetics of mezlocillin in healthy volunteers
@en
type
label
Pharmacokinetics of mezlocillin in healthy volunteers
@en
prefLabel
Pharmacokinetics of mezlocillin in healthy volunteers
@en
P2860
P356
P1476
Pharmacokinetics of mezlocillin in healthy volunteers
@en
P2093
P2860
P304
P356
10.1128/AAC.14.6.801
P407
P577
1978-12-01T00:00:00Z